Physician profile
Daniel Edwards
NPI 1487034146
$2,662.12
in general payments reported to CMS, 2019-2025
21 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2021: $180 · 2022: $769 · 2023: $350 · 2024: $397 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $628.20 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $324.27 | 2019-2022 | |
| Coloplast Corp | $240.75 | 2019-2024 | Speedicath |
| Urogen Pharma, INC. | $201.07 | 2022-2024 | Jelmyto |
| Pfizer INC. | $174.36 | 2021-2025 | |
| Blue Earth Diagnostics | $146.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.72 | 2019-2024 | |
| Abbvie INC. | $135.04 | 2022-2024 | Lupron Depot |
| Astellas Pharma US INC | $127.75 | 2019-2022 | |
| Intuitive Surgical, INC. | $97.15 | 2022 | |
| Janssen Scientific Affairs, LLC | $92.26 | 2019 | |
| Dendreon Pharmaceuticals LLC | $65.58 | 2019 | |
| Tempus Ai, INC | $55.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $52.55 | 2024-2025 | |
| Palette Life Sciences, INC. | $47.22 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $38.60 | 2022-2025 | Erleada |
| Sumitomo Pharma America, INC. | $30.46 | 2024-2025 | Orgovyx |
| Ferring Pharmaceuticals INC. | $17.77 | 2024 | Adstiladrin |
| Masimo Corporation | $15.23 | 2022 | |
| Medtronic USA, INC. | $14.54 | 2019 | |
| Foundation Medicine, INC. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.